Taiwan has become the latest APAC region to approve the use of 2'-fucosyllactose (2'-FL) – a human milk oligosaccharide (HMO) – in nutrition products for infant and young children, with firms hopeful of further sector growth as more authorities permit the use of the ingredient.
GALLERY: The 10 most read APAC health and nutrition stories in September
Infant formula industry competing on functional ingredients, milk base, organic claims – Growth Asia expert panel
Mining new opportunities: Herbs of Gold pharmacy expansion accelerates Australian market growth for Vita Life Sciences
Unilever’s exclusive insights: Four key trends driving APAC’s online supplements growth
